Show simple item record

dc.contributor.authorSa'aid, Hafizah Besaren_US
dc.contributor.authorStewart, Donalden_US
dc.contributor.authorEngland, Ianen_US
dc.contributor.editorJ. Okparaen_US
dc.date.accessioned2017-04-24T12:44:39Z
dc.date.available2017-04-24T12:44:39Z
dc.date.issued2011en_US
dc.date.modified2011-10-24T07:26:18Z
dc.identifier.issn1838-3955en_US
dc.identifier.doihttp://www.wbiaus.org/2.%20Hafizah.pdfen_AU
dc.identifier.urihttp://hdl.handle.net/10072/41254
dc.description.abstractNew health technologies have significantly improved health and quality of life. Nevertheless, they also create challenges in ensuring value for money and concerns over safety and efficacy. Health technology assessment (HTA) has been recognised as an essential tool in addressing these issues. However, concern about HTA dissemination and use by decision makers at institutional level has been expressed. This study explores health care decision makers' experiences concerning decision-making processes for the introduction and adoption of new health technologies at one group of not-for-profit private hospitals in South East Queensland. The aim of the study was to gain knowledge about HTA adoption at institutional level and suggest ways to encourage diffusion of HTA into practice. Thirteen in-depth, semi-structured interviews were conducted with key decision makers. Interviewees described decision-making processes as 'informal'. Safety and effectiveness were considered important, but cost and doctor demand were the standard drivers for decisions about the uptake of new technologies. The decision makers were generally unclear about HTA and its potential. Most information for decisions was based on information from suppliers, other hospitals within the group, and the people or departments who requested the product. The main areas identified for improvement were a desire to have a more formal process for evaluating new health technology, the need for unbiased and timely information, and the use of hospital based, or local HTA. Findings from this study show that the evidence provided by HTA is not being fully utilised by decision makers in this group of hospitals to make informed decisions.en_US
dc.description.peerreviewedYesen_US
dc.description.publicationstatusYesen_AU
dc.format.extent231717 bytes
dc.format.mimetypeapplication/pdf
dc.languageEnglishen_US
dc.language.isoen_AU
dc.publisherWorld Business Instituteen_US
dc.publisher.placeAustraliaen_US
dc.relation.ispartofstudentpublicationNen_AU
dc.relation.ispartofpagefrom10en_US
dc.relation.ispartofpageto19en_US
dc.relation.ispartofissue2en_US
dc.relation.ispartofjournalWorld Review of Business Researchen_US
dc.relation.ispartofvolume1en_US
dc.rights.retentionYen_AU
dc.subject.fieldofresearchHealth Care Administrationen_US
dc.subject.fieldofresearchcode111709en_US
dc.titleDecision Making Processes for Introducing New Health Technology at Institutional Level: Decision Makers’ Perspectiveen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Peer Reviewed (HERDC)en_US
dc.type.codeC - Journal Articlesen_US
gro.rights.copyrightCopyright 2011 World Business Institute. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.en_AU
gro.date.issued2011
gro.hasfulltextFull Text


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record